Abbott India has appointed Prithwish Kumar Banerji has been appointed as Commercial Director - Women’s Health, Metabolics and International Business with effect from January 3, 2025.

Prithwish has close to 28 years of experience in a Commercial role. He joins Abbott from Cipla, where he was a member of the Cipla Leadership Group. He was the designated Vice President and Vertical head for their flagship respiratory portfolio of Nebulization and Immunotherapy. Prithwish presents a blended experience in Sales, Marketing, Strategic Business Planning and Execution.

Prior to Cipla, Prithwish worked across Pharma MNCs and FMCG organizations like Unilever and GSK Consumer Healthcare. In the past, Prithwish had a small stint with Abbott Diabetes Care business as National Sales Manager.

Prithwish has proven success in establishing new entrants in the Indian Pharmaceutical Market, Patent Product Launches, and Go-to-Market models, creating winners across the industry spectrum - Pharmaceuticals, OTC/OTX, and FMCG.

Prithwish is an Honors graduate in Geology from St Xavier’s College, Ranchi, and holds an Executive Management Program in Management from IIM Lucknow.